Navigation Links
1 in 4 new HIV infections in Ontario are among women: Study
Date:5/31/2011

TORONTO, June 1, 2011 Despite significant clinical advances in HIV care, an estimated 25 per cent of new HIV infections in Ontario from 2006 to 2008 were among women, according to a health study by researchers from the Institute for Clinical Evaluative Sciences (ICES) and St. Michael's Hospital. The researchers say 93 per cent of new infections among women are acquired through sexual transmission and seven per cent through injection drug use. About 60 per cent of newly infected women are immigrants. The findings, the latest from the POWER (Project for an Ontario Women's Health Evidence-Based Report) study, suggest targeted prevention and intervention efforts are necessary to eliminate gaps and inequities in care for HIV patients.

"We have made real progress in preventing HIV infection and in treating people living with HIV, but we also identified several groups for whom important disparities persist, including older women, Aboriginal women, and women who have immigrated from countries where HIV is endemic," says Dr. Ahmed Bayoumi, lead author on the chapter and a physician at St. Michael's Hospital. "We also identified differences related to poverty, injection drug use, and geography. Our findings suggest that addressing such factors will be important for delivering universal, high-quality HIV care in Ontario."

The POWER Study a joint study from St. Michael's Hospital and ICES is the first in the province to provide a comprehensive overview of women's health in relation to income, education, ethnicity and geography. The findings are detailed in the report titled HIV Infection-the 11th chapter to be released as part of the study. Findings can be used by policymakers and health-care providers to improve access, quality and outcomes of care for Ontario women. The POWER Study was funded by Echo: Improving Women's Health in Ontario, an agency of the Ontario Ministry of Health and Long-Term Care.

"The POWER Study HIV Infection chapter reveals important gaps in prevention, access and clinical care," says Pat Campbell, CEO, Echo: Improving Women's Health in Ontario. "Findings support the need for strategies to promote HIV prevention and testing directed at hard to reach groups. We also need to improve access to care for women aged 55 and older to ensure earlier diagnosis and/or earlier entry to care. At the same time findings are helping to track improvements in care, evident in the high prenatal HIV screening rate (95%)."

The POWER study chapter, released today, examined the impact of HIV infection on Ontarians. Key findings include:

  • More than 4,700 women are living with HIV in Ontario, most of whom acquired HIV through sexual contact. This represents 18% of the estimated HIV infections in the province.

  • Women who emigrated from a country where HIV is endemic account for more than half of all new infections in 2008 among women.

  • Women reported lower rates of condom use than men.

  • Women who inject drugs report riskier injection behaviours than men.

  • One third of users of community based HIV services are women

  • Over 90% of HIV-positive pregnant women who knew their HIV status received antiretrovirals during pregnancy, which could prevent transmission to the newborn.

"High rates of prenatal HIV screening show that when we have an organized and targeted program we can achieve measurable improvements in care," says Dr. Arlene Bierman, a physician at St. Michael's Hospital and principal investigator of the study. "We need to develop programs that ensure that all women who are at risk are screened and when tests are positive that they receive HIV care in a timely manner. Routine monitoring of quality indicators will allow us to evaluate these programs," adds Dr. Bierman, also an ICES investigator.


'/>"/>

Contact: Julie Saccone
sacconej@smh.ca
416-864-5047
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. Burden of HIV/TB infections increasingly falling on Hispanic community
2. Heat Therapy Helps Treat U.S. Soldiers Infections
3. Studies Show Significant Increases of C. Difficile Infections (CDI)
4. U.S. Hospitals Get Low Marks on Curbing Infections
5. Vaccine Now Misses Many Pneumococcal Infections in Kids
6. Strep steps up in urinary tract infections
7. Nasal Saline Rinses Reduce Ear Infections in Kids
8. Hepatitis Infections Behind U.S. Rise in Liver Cancer
9. No Link Between Childhood Infections, Autism
10. Study: Yogurt-like drink DanActive reduced rate of common infections in daycare children
11. Henry Ford Hospital study: Fewer infections with new heart-pump implant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Pass, OR (PRWEB) , ... April 29, 2016 , ... ... suggest dinner as the meal to miss. That was among the many new lifestyle ... Nutrition, on a recent Sharon Kleyne Hour® Power of Water® radio show. Bonny and ...
(Date:4/29/2016)... ... , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. Mickey ... -- are proud of the recent release of their 2014 in vitro fertilization success ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows HRC/OC ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in ... efficacy of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The ... adding BC and AD, saying it is time to set the record straight. Traditionally, ... says this simply cannot possibly be true and offers explanation. , “To start with, ...
(Date:4/28/2016)... ... April 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. ... off. The discount is applied to the product with lesser value. In addition, a ... purchase $250 or more in products. , "So many women (men, too) love our products ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... At the Sachs CEO forum ... Phase 2 clinical study of its lead drug candidate, ... implantation (CI) surgery. This large, placebo-controlled, double-blind, phase 2 ... and France . STR001 ... time of surgery. "Despite advances in cochlear implant technology, ...
(Date:4/26/2016)... 2016 US demand for infection prevention ... percent annually to $27.6 billion in 2020.  Increasing ... decrease rates of healthcare-associated infections (HAIs) will boost ... services.  Although declining, the overall rate of certain ... set by the CDC.  Recent statistics indicate that ...
Breaking Medicine Technology: